Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Active Transdermal Drug Delivery Device market report explains the definition, types, applications, major countries, and major players of the Active Transdermal Drug Delivery Device market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
3M
Corium International, Inc
Noven Pharmaceuticals, Inc
Actavis, Inc
Transdermal Corp
Boehringer Ingelheim GmbH
Mylan NV
Johnson & Johnson (Janssen Pharmaceuticals Inc)
Novartis AG
GlaxoSmithKline plc
Echo Therapeutics, Inc
Bayer AG
By Type:
Patches
Gels
By End-User:
Clinic
Hospital
Home Use
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Active Transdermal Drug Delivery Device Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Active Transdermal Drug Delivery Device Outlook to 2028- Original Forecasts
-
2.2 Active Transdermal Drug Delivery Device Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Active Transdermal Drug Delivery Device Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Active Transdermal Drug Delivery Device Market- Recent Developments
-
6.1 Active Transdermal Drug Delivery Device Market News and Developments
-
6.2 Active Transdermal Drug Delivery Device Market Deals Landscape
7 Active Transdermal Drug Delivery Device Raw Materials and Cost Structure Analysis
-
7.1 Active Transdermal Drug Delivery Device Key Raw Materials
-
7.2 Active Transdermal Drug Delivery Device Price Trend of Key Raw Materials
-
7.3 Active Transdermal Drug Delivery Device Key Suppliers of Raw Materials
-
7.4 Active Transdermal Drug Delivery Device Market Concentration Rate of Raw Materials
-
7.5 Active Transdermal Drug Delivery Device Cost Structure Analysis
-
7.5.1 Active Transdermal Drug Delivery Device Raw Materials Analysis
-
7.5.2 Active Transdermal Drug Delivery Device Labor Cost Analysis
-
7.5.3 Active Transdermal Drug Delivery Device Manufacturing Expenses Analysis
8 Global Active Transdermal Drug Delivery Device Import and Export Analysis (Top 10 Countries)
-
8.1 Global Active Transdermal Drug Delivery Device Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Active Transdermal Drug Delivery Device Export by Region (Top 10 Countries) (2017-2028)
9 Global Active Transdermal Drug Delivery Device Market Outlook by Types and Applications to 2022
-
9.1 Global Active Transdermal Drug Delivery Device Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Patches Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Gels Consumption and Growth Rate (2017-2022)
-
9.2 Global Active Transdermal Drug Delivery Device Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Home Use Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Active Transdermal Drug Delivery Device Market Analysis and Outlook till 2022
-
10.1 Global Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.2.2 Canada Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.2.3 Mexico Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.3.2 UK Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.3.3 Spain Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.3.4 Belgium Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.3.5 France Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.3.6 Italy Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.3.7 Denmark Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.3.8 Finland Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.3.9 Norway Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.3.10 Sweden Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.3.11 Poland Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.3.12 Russia Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.3.13 Turkey Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.4.2 Japan Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.4.3 India Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.4.4 South Korea Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.4.5 Pakistan Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.4.6 Bangladesh Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.4.7 Indonesia Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.4.8 Thailand Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.4.9 Singapore Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.4.10 Malaysia Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.4.11 Philippines Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.4.12 Vietnam Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.5.2 Colombia Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.5.3 Chile Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.5.4 Argentina Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.5.5 Venezuela Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.5.6 Peru Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.5.7 Puerto Rico Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.5.8 Ecuador Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.6.2 Kuwait Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.6.3 Oman Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.6.4 Qatar Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.6.5 Saudi Arabia Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.6.6 United Arab Emirates Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.7.2 South Africa Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.7.3 Egypt Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.7.4 Algeria Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Active Transdermal Drug Delivery Device Consumption (2017-2022)
-
10.8.2 New Zealand Active Transdermal Drug Delivery Device Consumption (2017-2022)
11 Global Active Transdermal Drug Delivery Device Competitive Analysis
-
11.1 3M
-
11.1.1 3M Company Details
-
11.1.2 3M Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 3M Active Transdermal Drug Delivery Device Main Business and Markets Served
-
11.1.4 3M Active Transdermal Drug Delivery Device Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Corium International, Inc
-
11.2.1 Corium International, Inc Company Details
-
11.2.2 Corium International, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Corium International, Inc Active Transdermal Drug Delivery Device Main Business and Markets Served
-
11.2.4 Corium International, Inc Active Transdermal Drug Delivery Device Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Noven Pharmaceuticals, Inc
-
11.3.1 Noven Pharmaceuticals, Inc Company Details
-
11.3.2 Noven Pharmaceuticals, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Noven Pharmaceuticals, Inc Active Transdermal Drug Delivery Device Main Business and Markets Served
-
11.3.4 Noven Pharmaceuticals, Inc Active Transdermal Drug Delivery Device Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Actavis, Inc
-
11.4.1 Actavis, Inc Company Details
-
11.4.2 Actavis, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Actavis, Inc Active Transdermal Drug Delivery Device Main Business and Markets Served
-
11.4.4 Actavis, Inc Active Transdermal Drug Delivery Device Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Transdermal Corp
-
11.5.1 Transdermal Corp Company Details
-
11.5.2 Transdermal Corp Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Transdermal Corp Active Transdermal Drug Delivery Device Main Business and Markets Served
-
11.5.4 Transdermal Corp Active Transdermal Drug Delivery Device Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Boehringer Ingelheim GmbH
-
11.6.1 Boehringer Ingelheim GmbH Company Details
-
11.6.2 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Main Business and Markets Served
-
11.6.4 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Mylan NV
-
11.7.1 Mylan NV Company Details
-
11.7.2 Mylan NV Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Mylan NV Active Transdermal Drug Delivery Device Main Business and Markets Served
-
11.7.4 Mylan NV Active Transdermal Drug Delivery Device Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Johnson & Johnson (Janssen Pharmaceuticals Inc)
-
11.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc) Company Details
-
11.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc) Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc) Active Transdermal Drug Delivery Device Main Business and Markets Served
-
11.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc) Active Transdermal Drug Delivery Device Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Novartis AG
-
11.9.1 Novartis AG Company Details
-
11.9.2 Novartis AG Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Novartis AG Active Transdermal Drug Delivery Device Main Business and Markets Served
-
11.9.4 Novartis AG Active Transdermal Drug Delivery Device Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 GlaxoSmithKline plc
-
11.10.1 GlaxoSmithKline plc Company Details
-
11.10.2 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Main Business and Markets Served
-
11.10.4 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Echo Therapeutics, Inc
-
11.11.1 Echo Therapeutics, Inc Company Details
-
11.11.2 Echo Therapeutics, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Echo Therapeutics, Inc Active Transdermal Drug Delivery Device Main Business and Markets Served
-
11.11.4 Echo Therapeutics, Inc Active Transdermal Drug Delivery Device Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Bayer AG
-
11.12.1 Bayer AG Company Details
-
11.12.2 Bayer AG Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Bayer AG Active Transdermal Drug Delivery Device Main Business and Markets Served
-
11.12.4 Bayer AG Active Transdermal Drug Delivery Device Product Portfolio
-
11.12.5 Recent Research and Development Strategies
12 Global Active Transdermal Drug Delivery Device Market Outlook by Types and Applications to 2028
-
12.1 Global Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Patches Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Gels Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Home Use Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Active Transdermal Drug Delivery Device Market Analysis and Outlook to 2028
-
13.1 Global Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.2.2 Canada Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.2.3 Mexico Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.3.2 UK Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.3.3 Spain Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.3.4 Belgium Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.3.5 France Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.3.6 Italy Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.3.7 Denmark Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.3.8 Finland Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.3.9 Norway Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.3.10 Sweden Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.3.11 Poland Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.3.12 Russia Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.3.13 Turkey Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.4.2 Japan Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.4.3 India Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.4.4 South Korea Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.4.8 Thailand Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.4.9 Singapore Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.4.11 Philippines Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.5.2 Colombia Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.5.3 Chile Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.5.4 Argentina Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.5.6 Peru Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.6.3 Oman Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.6.4 Qatar Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.7.2 South Africa Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.7.3 Egypt Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.7.4 Algeria Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Active Transdermal Drug Delivery Device Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Active Transdermal Drug Delivery Device
-
Figure of Active Transdermal Drug Delivery Device Picture
-
Table Global Active Transdermal Drug Delivery Device Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Active Transdermal Drug Delivery Device Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Patches Consumption and Growth Rate (2017-2022)
-
Figure Global Gels Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Home Use Consumption and Growth Rate (2017-2022)
-
Figure Global Active Transdermal Drug Delivery Device Consumption by Country (2017-2022)
-
Table North America Active Transdermal Drug Delivery Device Consumption by Country (2017-2022)
-
Figure United States Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Canada Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Mexico Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Table Europe Active Transdermal Drug Delivery Device Consumption by Country (2017-2022)
-
Figure Germany Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure UK Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Spain Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Belgium Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure France Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Italy Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Denmark Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Finland Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Norway Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Sweden Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Poland Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Russia Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Turkey Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Table APAC Active Transdermal Drug Delivery Device Consumption by Country (2017-2022)
-
Figure China Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Japan Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure India Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure South Korea Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Thailand Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Singapore Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Philippines Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Table South America Active Transdermal Drug Delivery Device Consumption by Country (2017-2022)
-
Figure Brazil Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Colombia Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Chile Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Argentina Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Peru Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Table GCC Active Transdermal Drug Delivery Device Consumption by Country (2017-2022)
-
Figure Bahrain Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Oman Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Qatar Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Table Africa Active Transdermal Drug Delivery Device Consumption by Country (2017-2022)
-
Figure Nigeria Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure South Africa Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Egypt Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure Algeria Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Table Oceania Active Transdermal Drug Delivery Device Consumption by Country (2017-2022)
-
Figure Australia Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Active Transdermal Drug Delivery Device Consumption and Growth Rate (2017-2022)
-
Table 3M Company Details
-
Table 3M Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
Table 3M Active Transdermal Drug Delivery Device Main Business and Markets Served
-
Table 3M Active Transdermal Drug Delivery Device Product Portfolio
-
Table Corium International, Inc Company Details
-
Table Corium International, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
Table Corium International, Inc Active Transdermal Drug Delivery Device Main Business and Markets Served
-
Table Corium International, Inc Active Transdermal Drug Delivery Device Product Portfolio
-
Table Noven Pharmaceuticals, Inc Company Details
-
Table Noven Pharmaceuticals, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
Table Noven Pharmaceuticals, Inc Active Transdermal Drug Delivery Device Main Business and Markets Served
-
Table Noven Pharmaceuticals, Inc Active Transdermal Drug Delivery Device Product Portfolio
-
Table Actavis, Inc Company Details
-
Table Actavis, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis, Inc Active Transdermal Drug Delivery Device Main Business and Markets Served
-
Table Actavis, Inc Active Transdermal Drug Delivery Device Product Portfolio
-
Table Transdermal Corp Company Details
-
Table Transdermal Corp Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
Table Transdermal Corp Active Transdermal Drug Delivery Device Main Business and Markets Served
-
Table Transdermal Corp Active Transdermal Drug Delivery Device Product Portfolio
-
Table Boehringer Ingelheim GmbH Company Details
-
Table Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Main Business and Markets Served
-
Table Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product Portfolio
-
Table Mylan NV Company Details
-
Table Mylan NV Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan NV Active Transdermal Drug Delivery Device Main Business and Markets Served
-
Table Mylan NV Active Transdermal Drug Delivery Device Product Portfolio
-
Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Company Details
-
Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Active Transdermal Drug Delivery Device Main Business and Markets Served
-
Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Active Transdermal Drug Delivery Device Product Portfolio
-
Table Novartis AG Company Details
-
Table Novartis AG Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Active Transdermal Drug Delivery Device Main Business and Markets Served
-
Table Novartis AG Active Transdermal Drug Delivery Device Product Portfolio
-
Table GlaxoSmithKline plc Company Details
-
Table GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Active Transdermal Drug Delivery Device Main Business and Markets Served
-
Table GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product Portfolio
-
Table Echo Therapeutics, Inc Company Details
-
Table Echo Therapeutics, Inc Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
Table Echo Therapeutics, Inc Active Transdermal Drug Delivery Device Main Business and Markets Served
-
Table Echo Therapeutics, Inc Active Transdermal Drug Delivery Device Product Portfolio
-
Table Bayer AG Company Details
-
Table Bayer AG Active Transdermal Drug Delivery Device Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Active Transdermal Drug Delivery Device Main Business and Markets Served
-
Table Bayer AG Active Transdermal Drug Delivery Device Product Portfolio
-
Figure Global Patches Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gels Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Active Transdermal Drug Delivery Device Consumption Forecast by Country (2022-2028)
-
Table North America Active Transdermal Drug Delivery Device Consumption Forecast by Country (2022-2028)
-
Figure United States Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Active Transdermal Drug Delivery Device Consumption Forecast by Country (2022-2028)
-
Figure Germany Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Active Transdermal Drug Delivery Device Consumption Forecast by Country (2022-2028)
-
Figure China Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Active Transdermal Drug Delivery Device Consumption Forecast by Country (2022-2028)
-
Figure Brazil Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Active Transdermal Drug Delivery Device Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Active Transdermal Drug Delivery Device Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Active Transdermal Drug Delivery Device Consumption Forecast by Country (2022-2028)
-
Figure Australia Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Active Transdermal Drug Delivery Device Consumption Forecast and Growth Rate (2022-2028)
-
